ALR/LtJ

Stock number: 003070
Strain synonyms: Alloxan Resistance
Research areas: Diabetes and Obesity Research, Immunology, Inflammation and Autoimmunity Research, Metabolism Research, Neurobiology Research, Research Tools, Sensorineural Research

Description

Mice of the inbred strain, ALR/LtJ, mice are resistant to alloxan or streptozotocin, and do not develop type 1 insulin dependent diabetes.

Detailed description

ALS/LtJ (Stock No. 003072) and ALR/LtJ inbred strains are of interest to investigators across a wide range of scientific disciplines including type 1 and type 2 diabetes, obesity, metabolism and toxicology research. Treatment of alloxan or streptozotocin causing pancreatic beta cell destruction, leads to severe hyperglycemia and hypoinsulinemia in ALS/LtJ mice. ALR/LtJ mice are resistant to these toxins. ALR/LtJ mice are of particular interest to investigators studying the immunogenetics of NOD/ShiLtJ mice in that the ALR/LtJ MHC haplotype (H2^gx) is a variant of the diabetogenic NOD H2^g7 haplotype. The (H2^gx) haplotype is identical to the H2^g7 haplotype from the H2-K end of the complex through the class II and class III region distal to Hsp70. However, at the distal H2-D end of the complex, ALR/LtJ mice have a rare H2-D^gx allele. Despite the similarities to the NOD/ShiLtJ mice, ALR/LtJ mice do not develop type 1 insulin dependent diabetes and thus provide an important control strain for NOD/ShiLtJ. ALR/Lt islets are unusually resistant in vitro to beta cell selective toxins known to generate free radicals (alloxan and streptozotocin). In addition, ALR/Lt islets are resistant to cytokine-mediated destruction. This resistance is correlated with an ALR strain-specific systematic elevation of enzymes and molecules associated with dissipation of free radicals. ALR/Lt mice of both sexes not treated with alloxan exhibit normal glucose tolerance, but gain weight rapidly, with females exhibiting male-like weight at 50 weeks of age. Understanding the genetic basis for the resistance of ALR mice to free radical mediated stressors, like alloxan and streptozotocin, as well as to immune system mediated stress, should prove valuable to pharmacologists interested in a variety of autoimmune and other diseases in which reactive oxygen species are associated with pathology.

Development

Alloxan is a pancreatic beta cell-selective toxin that induces diabetes in rodents by generating cytotoxic free radicals. The ALR (alloxan-induced diabetes-resistant) inbred strain was created in Japan by selective inbreeding of Crj:CD-1 (ICR) mice with selection for resistance to diabetes development after administration of alloxan at doses representing the ED50 for the original Crj:CD-1 strain (45 mg/kg in males, 47 mg/kg in females). These dosages are lower than what is necessary to elicit a strong diabetogenic response in most inbred strains, typically 60mg/kg. After a litter was born and weaned, the parents and some of the progeny were alloxan-treated to select for low versus high [ALS (alloxan-induced diabetes-susceptible)] incidence lines based on blood glucose levels at 7 days post treatment. ALS and ALR inbred strains were obtained from Japan by Dr. EH Leiter (Lt) at The Jackson Laboratory in 1996. ALS/Lt and ALR/Lt mice were transferred to the production colony in 1998. Genome wide scan demonstrated that ALR/LtJ mice are not only closely related to ALS/Lt mice, but also to two other ICR-derived inbred strains selected for diabetes susceptibility and distributed by The Jackson Laboratory: NOD/LtJ and NON/LtJ.

Allele

Symbol: Cdh23^ahl
Name: age related hearing loss 1
MGI accession ID: MGI:3028349
Generation method: Spontaneous
Synonyms: Cdh23^753A; mdfw
Marker symbol: Cdh23
Marker name: cadherin 23 (otocadherin)
Marker synonyms: 4930542A03Rik; ahl; bob; CDHR23; mdfw; nmf112; nmf181; nmf252; PITA5; sals; USH1D
Chromosome: 10
Strain of origin: multiple strains
Molecular note: Genetic complementation tests have shown allelism between the mdfw (modifier of deaf waddler) locus and the ahl locus. Further analysis has shown this is caused by a G to A transition at coding nucleotide position 753 of Cdh23 (SNP rs257098870). This hypomorphic allele changes splice donor site G-GT to A-GT, causing frame skipping of exon 7. This is predicted to delete part of the 2nd and 3rd ectodomains in the encoded peptide and cause reduced message stability. Twenty-seven strains classified with ahl and carrying the 753A allele include: CD-1, RBF/DnJ, PL/J, AKR/J, RF/J, BALB/cBy, A/WySnJ, P/J, SENCARA/PtJ, DBA/1J, ALS/LtJ, C58/J, C57BLKS/J, 129P1/ReJ, C57BR/cd, SKH2/J, BUB/Bn, MA/MyJ, LP/J, 129X1/SvJ, NOR/LtJ, A/J, C57BL/6, NOD/LtJ, DBA/2J, ALR/LtJ, C57L/J. Strains classified with ahl that DO NOT carry this mutation include: 129S1/SvImJ, C3H/HeSnJ, I/LnJ, YBR/Ei, MRL/MpJ.

Allele

Symbol: mt-Tr^m2
Name: mutation 2
MGI accession ID: MGI:3832223
Generation method: Spontaneous
Synonyms: 9A
Marker symbol: mt-Tr
Marker name: mitochondrially encoded tRNA arginine
Marker synonyms: MTTR; tRNA; tRNA-Arg; TrnR tRNA
Chromosome: MT
Strain of origin: various
Molecular note: The adenine repeat in the D stem is polymorphic with 9 adenines in this allele.
General note: This polymorphism is present in ALR/Lt, NOD/ShiLtDvs, and SKH2/J. A variant with 10 adenines is found in A/J, ALS/Lt, NOD/ShiLtJ and NZB/B1NJ.